Autologous Stem Cell Transplantation Offsets Differences between Doublet and Triplet Induction in Multiple Myeloma: Real-World Data from a Middle-Income Country.

Key Points

• Autologous stem cell transplantation reduces differences in outcomes between doublet and triplet induction.
• Key evidence shows that treatment outcomes are balanced, with implications for therapy approaches in multiple myeloma.
• The analysis focuses on real-world data from a middle-income country regarding treatment regimens.
• These findings underscore the need for tailored approaches in multiple myeloma care to optimize patient results.